Urology
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 9,801 |
| Other procedure on male genital system | 9,802 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 10,211 |
| Ketone bodies analysis, quantitative | 10,229 |
| Total protein level, urine | 10,247 |
| Urine hemoglobin level | 10,459 |
| Glucose (sugar) level on body fluid | 10,464 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 10,892 |
| Bilirubin level, total | 11,374 |
| Measurement of total estradiol (hormone) | 13,223 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 13,328 |
| Blood test, comprehensive group of blood chemicals | 13,899 |
| Complicated insertion of bladder tube | 13,934 |
| Cell examination of specimen, selective cellular enhancement technique | 14,036 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 14,057 |
| Urinalysis using microscope | 14,863 |
| Telephone medical discussion with physician, 21-30 minutes | 15,156 |
| Injection, medroxyprogesterone acetate, 1 mg | 16,152 |
| Urinalysis for bacteria | 17,129 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 17,483 |
| Telephone medical discussion with physician, 5-10 minutes | 17,991 |
| Chemical analysis using spectrophotometry (light) | 18,284 |
| Sex hormone binding globulin (protein) level | 18,510 |
| Dilation of urethra using an endoscope | 19,058 |
| Ct scan of abdomen and pelvis before and after contrast | 19,422 |
| Detection test by nucleic acid for organism, quantification | 20,437 |
| Shock wave crushing of kidney stones | 21,073 |
| Ct scan of abdomen and pelvis without contrast | 21,757 |
| Blood creatinine level | 22,169 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 24,258 |
| Insertion of temporary bladder tube | 26,779 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 27,217 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 27,422 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 28,657 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 29,940 |
| Blood test, basic group of blood chemicals (calcium, total) | 31,508 |
| Telephone medical discussion with physician, 11-20 minutes | 31,772 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 34,589 |
| New patient office or other outpatient visit, 60-74 minutes | 34,793 |
| Simple change of bladder tube | 35,319 |
| Bacterial culture for aerobic isolates | 36,981 |
| Insertion of lower leg neurostimulator electrode | 38,438 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 38,648 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 39,144 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 39,418 |
| Unclassified drugs | 40,632 |
| Psa (prostate specific antigen) measurement, free | 40,858 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 42,031 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 42,909 |
| Ultrasonic guidance for needle placement | 43,304 |
| Insertion of device into abdomen with pressure and urine flow rate study | 43,963 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 46,608 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 50,844 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 54,206 |
| Complete ultrasound scan of pelvis | 54,322 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 55,143 |
| Instillation of anti-cancer drug into bladder | 55,397 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 57,302 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 58,121 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 58,163 |
| Bacterial urine culture | 58,372 |
| X-ray of abdomen, 1 view | 62,283 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 64,756 |
| Simple bladder irrigation and/or instillation | 74,709 |
| Limited ultrasound scan of pelvis | 74,773 |
| Testosterone (hormone) level, total | 75,219 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 79,446 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 80,905 |
| Insertion of stent in ureter using an endoscope | 86,721 |
| Imaging of urinary tract following injection of a contrast agent | 89,653 |
| Simple insertion of temporary bladder tube | 93,547 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 102,734 |
| Limited ultrasound scan behind abdominal cavity | 103,582 |
| Biopsy of prostate gland | 107,562 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 108,333 |
| Identification of organisms by genetic analysis, amplified probe technique | 109,979 |
| Bacterial colony count, urine | 117,581 |
| Complete ultrasound scan behind abdominal cavity | 125,570 |
| Detection test for candida species (yeast), amplified probe technique | 132,480 |
| Creatinine level to test for kidney function or muscle injury | 141,069 |
| Established patient office or other outpatient visit, 10-19 minutes | 147,125 |
| Established patient office or other outpatient visit, 40-54 minutes | 151,245 |
| Ultrasound scan of pelvic region through rectum | 152,788 |
| Injection of drug or substance under skin or into muscle | 167,951 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 170,142 |
| New patient office or other outpatient visit, 30-44 minutes | 183,633 |
| Electronic assessment of bladder emptying | 232,413 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 255,945 |
| Manual urinalysis test with examination using microscope, non-automated | 277,208 |
| Psa (prostate specific antigen) measurement, total | 383,557 |
| Manual urinalysis test with examination using microscope, automated | 413,237 |
| Detection test by nucleic acid for organism, amplified probe technique | 566,382 |
| New patient office or other outpatient visit, 45-59 minutes | 573,163 |
| Urinalysis, manual test | 602,429 |
| Diagnostic exam of bladder and urethra using an endoscope | 678,956 |
| Insertion of needle into vein for collection of blood sample | 700,532 |
| Ultrasound measurement of bladder capacity after voiding | 1,384,063 |
| Automated urinalysis test | 1,748,644 |
| Established patient office or other outpatient visit, 20-29 minutes | 2,058,443 |
| Established patient office or other outpatient visit, 30-39 minutes | 2,711,959 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).